ANAL NON-KERATINIZING SQUAMOUS CELL CARCINOMA

Clinical trials for ANAL NON-KERATINIZING SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ANAL NON-KERATINIZING SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for ANAL NON-KERATINIZING SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Tailored attack on HIV-Linked anal cancer tests gentler vs. stronger approach

Disease control Recruiting now

This study is testing two personalized treatment plans for anal cancer in people living with HIV. For patients with low-risk cancer, researchers are testing a reduced dose of chemotherapy and radiation to see if it's effective with fewer side effects. For patients with high-risk …

Matched conditions: ANAL NON-KERATINIZING SQUAMOUS CELL CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

ANAL NON-KERATINIZING SQUAMOUS CELL CARCINOMA

Get alerted when new ANAL NON-KERATINIZING SQUAMOUS CELL CARCINOMA trials appear

Tailored attack on HIV-Linked anal cancer tests gentler vs. stronger approach